Trends in the Location of Phase 3 Clinical Trials Between 2008 and 2012: A Retrospective Review Utilizing ClinicalTrials.gov-Reference-Cited by-同舟云学术

Trends in the Location of Phase 3 Clinical Trials Between 2008 and 2012: A Retrospective Review Utilizing ClinicalTrials.gov

Published:2016-01-29 Issue:2 Volume:30 Page:109-115
ISSN:1178-2595
Container-title:Pharmaceutical Medicine
language:en
Short-container-title:Pharm Med

Author:

Glass Harold E.,Glass Lucas M.,Tran Phuong,Jain Ananya

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s40290-015-0135-1.pdf

Reference30 articles.

1. Centerwatch: Korieth K, Anderson A. New growth and decline in Asia clinical trials. The CenterWatch Monthly. 2013. 20(10). Retrieved from: http://www.ppdi.com/~/media/Files/PPDI%20Files/Expert%20Community/Articles/CenterWatch-Monthly-2013-Oct-Clinical-Trial-Demands_Asia.ashx . Accessed 30 May 2014.

2. Rezaie R, McGahan A, Frew S, Daar A, Singer P. Emergence of biopharmaceutical innovators in China, India, Brazil and South Africa as global competitors and collaborators. Health Res Policy Syst. 2012;10:18.

3. George M, Selvarajan S, Kumar S, Dkhar S, Chandrasekaran A. Globalization of Clinical Trials—Where are we heading? Curr Clin Pharmacol. 2013;8(2):115–23.

4. Brooks K. CRO outlook and market trends—innovation tied to globalization and collaboration. Contract Pharma. 2013. Retrieved from: http://www.contractpharma.com/issues/2013-06/view_features/cro-outlook-market-trends/ . Accessed 30 May 2014.

5. ProPhase Times. Where Clinical Trials Are Headed. 2014;2(5):3. Retrieved from: http://prophase.com/wp-content/uploads/2014/05/Newsletter_Volume2_Issue5.pdf . Accessed 30 May 2014.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Open Payments and the US Clinical Landscape;Therapeutic Innovation & Regulatory Science;2020-01-06

2. Evaluating the Completeness of ClinicalTrials.gov;Therapeutic Innovation & Regulatory Science;2019-05

3. Open Payments and the US Clinical Landscape;Therapeutic Innovation & Regulatory Science;2019-04-13